English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

MPS-Authors
/persons/resource/persons15947

Urlaub,  H.
Research Group of Bioanalytical Mass Spectrometry, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons208298

Liepe,  J.
Research Group of Quantitative and System Biology, MPI for Biophysical Chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)

3398348.pdf
(Publisher version), 5MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Mishto, M., Rodriguez-Hernandez, G., Neefjes, J., Urlaub, H., & Liepe, J. (2021). Response: Commentary: An In Silico–In Vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients. Frontiers in Immunology, 12: 679836. doi:10.3389/fimmu.2021.679836.


Cite as: http://hdl.handle.net/21.11116/0000-000A-D2A4-F
Abstract
There is no abstract available